Skip to content

Comparing Mulailadi Kashaya and Palasha twak Kashaya for Udavartini Yonivyapad (Primary Dysmenorrhea)

A COMPARITIVE CLINICAL STUDY OF MULAILADI KASHAYA AND PALASHA TWAK KASHAYA IN UDAVARTINI YONIVYAPAD (PRIMARY DYSMENORRHEA) - NIL

Status
Active, not recruiting
Phases
Phase 2Phase 3
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2025/12/099575
Enrollment
40
Registered
2025-12-22
Start date
Unknown
Completion date
Unknown
Last updated
2026-01-12

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: N944- Primary dysmenorrhea

Interventions

None listed

Sponsors

Dr Praveena K
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1.Patients fulfilling the diagnostic criteria 2. Women aged between 13 to 30 years 3. History of painful menstruation for atleast 2 consecutive menstrual cycles. 4. Patient with regular menstrual cycles (21-35 days)

Exclusion criteria

Exclusion criteria: 1.Cases of secondary dysmenorrhea with pelvic pathology- Fibroid Uterus, Endometriosis, Adenomyosis, AUB, PID, Ovarian cyst, Cervicitis. 2. Patients with Congenital anomalies of Reproductive tract 3. Patients with systemic diseases like Diabetes Mellitus, Hypertension, Anaemia 4.Patients on Hormonal therapy, contraception and Intra uterine contraceptive device. 5.Endocrinal disorders like thyroid abnormalities and PCOS 6. Surgical and Malignant conditions 7.Any Systemic infections

Design outcomes

Primary

MeasureTime frame
1.Intensity of pain 2.Site of pain 3.Pain associated with symptoms such as Low back ache,Headache,Nausea,Vomiting and Constipation 4. Duration of pain 5. Nature of painTimepoint: 1st 2nd 3rd 4th of 2 consecutive menstrual cycle during treatment and follow up

Secondary

MeasureTime frame
Changes in the WaLidd Scale for pain assesmentTimepoint: 1st 2nd 3rd 4th of 2 consecutive menstrual cycle during treatment and follow up

Countries

India

Contacts

Public ContactDr Praveena K

ALVAS AYURVEDA MEDICAL COLLEGE

drsumaranirajesh@gmail.com9449664617

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026